Source of Human Milk Fortifier & Intestinal Oxygenation in Preterm Infants

Status Not yet recruiting

Clinical Trial Summary

Preterm infants require higher nutritional intakes during the neonatal phase than they do at any other stage of their development. Standard volumes of human milk alone do not offer sufficient nourishment to these infants. There are multiple options for fortifying human milk, which vary depending on whether the fortifier is derived from bovine sources (B-HMF) or human sources (H-HMF). Fortifying human milk has been proven to enhance growth in preterm infants without raising the risk of necrotizing enterocolitis (NEC), though it could potentially affect feeding tolerance. Changes in blood flow and oxygen levels in the intestines are commonly observed in infants experiencing feeding intolerance. Research indicates that feeding a mother's own milk (MOM) doesn't affect splanchnic (intestinal) oxygenation, whereas it decreases when feeding bovine-derived human milk fortifiers (B-HMF) or preterm formula, indicating greater oxygen requirements in the intestines of preterm infants fed these alternatives. The goal of this clinical trial is to compare the effect of H-HMF and B-HMF on splanchnic oxygenation in infants less than 30 weeks.

Clinical Trial Description

The fortification of human milk has been proven to enhance growth without raising the risk of necrotizing enterocolitis, although it may affect feeding tolerance. Non-invasive techniques like Doppler ultrasonography of the superior mesenteric artery (SMA) and near-infrared spectroscopy (NIRS) have been utilized to evaluate mesenteric blood flow and intestinal oxygenation in preterm infants. Numerous studies have investigated the relationship between SMA flow and feeding intolerance. Findings indicate a significant correlation between increased mean Superior Mesenteric Artery blood flow velocity and early tolerance of enteral feeding. Moreover, research suggests a higher incidence of necrotizing enterocolitis (NEC) in preterm infants exhibiting increased resistance patterns of SMA blood flow velocity on the first day. Non-invasive monitoring methods offer the ability to assess the impact of various fortification products on intestinal perfusion and oxygenation. This could aid in determining the most suitable fortification product to minimize episodes of feeding intolerance. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06336668
Study type	Interventional
Source	University of Calgary
Contact	Belal AlShaikh, MD, MSCE
Phone	(403) 956 1588
Email	balshaik@ucalgary.ca
Status	Not yet recruiting
Phase	N/A
Start date	April 1, 2024
Completion date	February 28, 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03926390` - Gut Priming With Oral Bovine Colostrum for Preterm Neonates; Randomized Control Trial	N/A
Completed	`NCT03380013` - OMT to Improve Feeding After Hypothermia	N/A
Completed	`NCT05687708` - Effect of Non-nutritive Sucking on Transition to Oral Feeding in Infants With Asphyxia	N/A
Completed	`NCT05729828` - Psychometric Properties of the SMART Feeding Tool
Not yet recruiting	`NCT04599010` - Role of Body Composition in Large for Gestational Age Infants (LGA) With Oral Feeding Difficulty	N/A
Not yet recruiting	`NCT04812249` - Effect of Co-morbidities on the Development of Oral Feeding Ability in Pre-term Infants
Completed	`NCT01603368` - Prophylactic Probiotics to Extremely Low Birth Weight Prematures	Phase 2
Withdrawn	`NCT01337921` - A Multi-strain Synbiotic Versus a Multi-strain Probiotic in Premature Infants	N/A
Not yet recruiting	`NCT05861531` - Learning to Talk, Learning to Eat: A Randomized Controlled Trial to Improve NICU Oral Feeding and Language Outcomes	N/A
Recruiting	`NCT05525091` - Neoneur Feeding System Functionality in the Clinic	N/A
Completed	`NCT03369093` - RCT of Efficacy of Amoxicillin Over Ampicillin on Severe Pneumonia	N/A
Completed	`NCT05307497` - An Exploration of Antenatal Hand Expression.
Completed	`NCT03371927` - Effect of SINC Feeding Protocol on Weight Gain, Transition to Oral Feeding and the Length of Hospitalization	N/A
Completed	`NCT04400175` - Effects of a Valved Feeding System in Late-preterm Newborns: the Safe Oral Feeding Trial	N/A
Recruiting	`NCT04246333` - Duodenal Feeds in Very Low Birth Weight Infants	N/A
Completed	`NCT03280381` - Nifty Feeding Cup Versus Generic Medicine Cup Preterm Infants Who Have Difficulty Breastfeeding	N/A
Completed	`NCT04945967` - A New Intervention Method to Enhance Oral Feeding Ability in Premature Infants: A Randomized Controlled Trial	N/A
Completed	`NCT04025827` - Weight Patterns in the Month After Birth
Recruiting	`NCT05310851` - The Effect Of Oral Motor Stimulation And Nonnutritive Sucking To The Time Of Transition To Oral Nutrition In Preterm	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Source of Human Milk Fortifier and Intestinal Oxygenation in Preterm Infants <30 Weeks Gestation

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms